| Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics K Morita, F Wang, K Jahn, T Hu, T Tanaka, Y Sasaki, J Kuipers, S Loghavi, ... Nature communications 11 (1), 5327, 2020 | 308 | 2020 |
| Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax K Kim, A Maiti, S Loghavi, R Pourebrahim, TM Kadia, CR Rausch, ... Cancer 127 (20), 3772-3781, 2021 | 113 | 2021 |
| Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms AS Sperling, VA Guerra, JA Kennedy, Y Yan, JI Hsu, F Wang, AT Nguyen, ... Blood, The Journal of the American Society of Hematology 140 (16), 1753-1763, 2022 | 83 | 2022 |
| Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia F Wang, K Morita, CD DiNardo, K Furudate, T Tanaka, Y Yan, KP Patel, ... Nature communications 12 (1), 2607, 2021 | 79 | 2021 |
| Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer K Kubota, W Kobayashi, H Sakaki, H Nakagawa, T Kon, M Mimura, R Ito, ... Supportive care in cancer 23, 3323-3329, 2015 | 56 | 2015 |
| Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax CA Lachowiez, S Loghavi, K Furudate, G Montalban-Bravo, A Maiti, ... Blood advances 5 (8), 2173-2183, 2021 | 48 | 2021 |
| Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study CA Lachowiez, PK Reville, H Kantarjian, E Jabbour, G Borthakur, N Daver, ... The Lancet Haematology 9 (5), e350-e360, 2022 | 44 | 2022 |
| Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment K Kubota, R Ito, N Narita, Y Tanaka, K Furudate, N Akiyama, CH Chih, ... BMC cancer 22 (1), 368, 2022 | 42 | 2022 |
| Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid … S Loghavi, CD DiNardo, K Furudate, K Takahashi, T Tanaka, NJ Short, ... British journal of haematology 192 (6), 1054-1063, 2021 | 37 | 2021 |
| Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ... Nature communications 13 (1), 2801, 2022 | 34 | 2022 |
| Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia T Tanaka, K Morita, S Loghavi, F Wang, K Furudate, Y Sasaki, L Little, ... Blood, The Journal of the American Society of Hematology 138 (18), 1733-1739, 2021 | 26 | 2021 |
| Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib Y Sasaki, HM Kantarjian, NJ Short, F Wang, K Furudate, H Uryu, R Garris, ... Leukemia 36 (5), 1253-1260, 2022 | 20 | 2022 |
| Methotrexate-related lymphoproliferative disorder in patients with osteonecrosis of the jaw: a 3-case report and literature review K Furudate, A Satake, N Narita, W Kobayashi Journal of Oral and Maxillofacial Surgery 76 (1), 97-111, 2018 | 18 | 2018 |
| Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment CA Lachowiez, PK Reville, H Kantarjian, E Jabbour, G Borthakur, N Daver, ... American journal of hematology 97 (11), 1443-1452, 2022 | 16 | 2022 |
| Conclusiveness of Cochrane Reviews in physiotherapy: a systematic search and analytical review R Momosaki, M Tsuboi, Y Yasufuku, K Furudate, T Kamo, K Uda, ... International Journal of Rehabilitation Research 42 (2), 97-105, 2019 | 13 | 2019 |
| Oral‐maxillofacial trauma of a geriatric population in a super‐ageing country R Ito, K Kubota, A Inui, H Nakagawa, T Kon, N Narita, Y Tamura, T Oyama, ... Dental Traumatology 33 (6), 433-437, 2017 | 13 | 2017 |
| Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic–polycytidylic acid in U373MG human astrocytoma cells T Imaizumi, N Sakashita, Y Mushiga, H Yoshida, R Hayakari, F Xing, ... Neuroscience research 94, 10-16, 2015 | 13 | 2015 |
| Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant S El Hussein, CD DiNardo, K Takahashi, JD Khoury, H Fang, K Furudate, ... Bone marrow transplantation 57 (3), 370-376, 2022 | 9 | 2022 |
| Home visits by occupational therapists in acute hospital care: a systematic review M Fukumoto, T Watanabe, Y Yasufuku, K Furudate, R Momosaki International Journal of Rehabilitation Research 42 (3), 205-210, 2019 | 9 | 2019 |
| Falls due to loss of consciousness are associated with maxillofacial fracture severity R Ito, K Kubota, S Yaguchi, K Furudate, Y Tanaka, W Kobayashi Journal of Oral and Maxillofacial Surgery 78 (3), 423-429, 2020 | 8 | 2020 |
